These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2311173)

  • 1. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid.
    Schalhorn A; Kühl M; Stupp-Poutot G; Nüssler V
    Cancer Chemother Pharmacol; 1990; 25(6):440-4. PubMed ID: 2311173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of fluorouracil and folinic acid.
    Schalhorn A; Kühl M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects.
    Straw JA; Szapary D; Wynn WT
    Cancer Res; 1984 Jul; 44(7):3114-9. PubMed ID: 6609768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.
    Straw JA; Newman EM; Doroshow JH
    NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
    Schilsky RL; Ratain MJ
    J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion.
    Newman EM; Straw JA; Doroshow JH
    Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma kinetic study of folinic acid and 5-methyltetrahydrofolate in healthy volunteers and cancer patients by high-performance liquid chromatography.
    Payet B; Fabre G; Tubiana N; Cano JP
    Cancer Chemother Pharmacol; 1987; 19(4):319-25. PubMed ID: 3496173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b.
    Czejka MJ; Schüller J; Weiss C; Bandak S; Meyer B; Simon D
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):255-62. PubMed ID: 8983929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin).
    Straw JA; Newman EM
    Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829
    [No Abstract]   [Full Text] [Related]  

  • 10. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
    NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13C NMR analysis of the use of alternative donors to the tetrahydrofolate-dependent one-carbon pools in Saccharomyces cerevisiae.
    Pasternack LB; Littlepage LE; Laude DA; Appling DR
    Arch Biochem Biophys; 1996 Feb; 326(1):158-65. PubMed ID: 8579365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of some folates in the rat.
    Beavon JR; Blair JA
    Br J Nutr; 1975 May; 33(3):299-308. PubMed ID: 1079138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of leucovorin and levoleucovorin.
    Zittoun J; Tonelli AP; Marquet J; De Gialluly E; Hancock C; Yacobi A; Johnson JB
    Eur J Clin Pharmacol; 1993; 44(6):569-73. PubMed ID: 8405015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
    Zhao R; Gao F; Goldman ID
    Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies.
    Selhub J; Emmanouel D; Stavropoulos T; Arnold R
    Am J Physiol; 1987 Apr; 252(4 Pt 2):F750-6. PubMed ID: 3565582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse.
    Trotz M; Wegner C; Nau H
    Life Sci; 1987 Jul; 41(1):103-10. PubMed ID: 3110521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acid.
    Sips JH; van Tellingen O; Nooijen WJ; Rodenhuis S; Ten Bokkel Huinink WJ; Beijnen JH
    Cancer Chemother Pharmacol; 1994; 35(2):144-8. PubMed ID: 7987991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment.
    Tubiana-Mathieu N; Monjanel-Mouterde S; Lejeune C; Payet B; Catalin J; Carcassonne Y; Cano J
    Eur J Cancer; 1994; 30A(9):1281-4. PubMed ID: 7999413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.